California State Teachers Retirement System Talaris Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$1.09 - $2.09 $689 - $1,322	-633 Reduced 6.87%	8,575 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.94 - $1.64 $97 - $170	104 Added 1.14%	9,208 $9,000
Q3 2022 Nov 18, 2022	SELL	$2.3 - $5.03 $1,115 - $2,439	-485 Reduced 5.06%	9,104 $24,000
Q2 2022 Aug 15, 2022	BUY	$4.51 - $9.85 $2,151 - $4,698	477 Added 5.23%	9,589 $43,000
Q1 2022 May 16, 2022	SELL	$6.89 - $16.56 $17,548 - $42,178	-2,547 Reduced 21.85%	9,112 $90,000
Q4 2021 Feb 15, 2022	BUY	$12.18 - $17.0 $84,127 - $117,419	6,907 Added 145.35%	11,659 $178,000
Q3 2021 Nov 15, 2021	SELL	$11.61 - $15.99 $87,864 - $121,012	-7,568 Reduced 61.43%	4,752 $64,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $150,920 - $229,275	12,320 New	12,320 $181,000

Others Institutions Holding TALS

# of Institutions

Shares Held

75.7K

Call Options Held

Put Options Held

View Full List

About Talaris Therapeutics, Inc.

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

More about TALS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account